These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8354273)

  • 21. Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.
    Osborne CK; Hamilton B; Nover M; Ziegler J
    J Clin Invest; 1981 Apr; 67(4):943-51. PubMed ID: 6259217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
    Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
    Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
    Neri C; Colomb E; Roux-Dosseto M; Martin PM
    Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule?
    Ree AH; Knutsen HK; Landmark BF; Eskild W; Hansson V
    Endocrinology; 1992 Oct; 131(4):1810-4. PubMed ID: 1382961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.
    Poulsom R; Hanby AM; Lalani EN; Hauser F; Hoffmann W; Stamp GW
    J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.
    Ormandy CJ; Lee CS; Kelly PA; Sutherland RL
    J Cell Biochem; 1993 May; 52(1):47-56. PubMed ID: 8320275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro.
    Chen H; Tritton TR; Kenny N; Absher M; Chiu JF
    J Cell Biochem; 1996 Apr; 61(1):9-17. PubMed ID: 8726350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in vitro.
    Koehorst SG; Spapens ME; Van Der Kallen CJ; Van 'T Verlaat JW; Blaauw G; Thijssen JH; Blankenstein MA
    Int J Biol Markers; 1998; 13(1):16-23. PubMed ID: 9681295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway.
    Espino PS; Li L; He S; Yu J; Davie JR
    Cancer Res; 2006 May; 66(9):4610-6. PubMed ID: 16651411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis.
    Tzukerman M; Zhang XK; Pfahl M
    Mol Endocrinol; 1991 Dec; 5(12):1983-92. PubMed ID: 1791843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase.
    Burak WE; Quinn AL; Farrar WB; Brueggemeier RW
    Breast Cancer Res Treat; 1997 May; 44(1):57-64. PubMed ID: 9164678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma.
    Takahashi H; Kida N; Fujii R; Tanaka K; Ohta M; Mori K; Hayashi K
    FEBS Lett; 1990 Feb; 261(2):283-6. PubMed ID: 2311759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of pS2 estrogen-inducible protein in primary breast cancer.
    Horiguchi J; Iino Y; Takei H
    Oncology; 1996; 53(1):12-5. PubMed ID: 8570124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5' flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells.
    Roberts M; Wallace J; Jeltsch JM; Berry M
    Biochem Biophys Res Commun; 1988 Feb; 151(1):306-13. PubMed ID: 2450536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
    Lu D; Kiriyama Y; Lee KY; Giguère V
    Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity.
    Issandou M; Bayard F; Darbon JM
    Cancer Res; 1988 Dec; 48(23):6943-50. PubMed ID: 3180102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.